Pfizer, Johnson and Johnson yet to apply for license of Covid-19 vaccines in India

The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation for their COVID-19 vaccine so that application is processed well in time but pharma companies have not applied for the license yet. According to the sources,drug regulators are […]

Research highlights critical role of immune system in ageing process

Researchers from the Buck Institute and Stanford University have created an inflammatory clock of ageing (iAge) which measures inflammatory load and predicts multi-morbidity, frailty, immune health, cardiovascular ageing and is also associated with exceptional longevity in centenarians. Utilizing deep learning, a form of AI, in studies of the blood immunome […]

Immune cells can be stimulated to boost effects of chemotherapy in pancreatic cancer: Study

A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer, such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy. The research was published in Cellular and Molecular […]

Discussions still going on over indemnity to Moderna: Sources

Even as the US giant drug maker Moderna’s COVID-19 messenger RNA (mRNA) vaccine is expected to reach India this week, discussions are still going on over indemnity waiver, informed sources. Earlier on June 29, Indian drug regulators granted permission to Cipla to import donated doses of Moderna from the US. These doses will be given to the […]

76 countries shows interest in India’s Covid vaccination platform software CoWin

The Modi government is planning to share CoWin — the tech backbone of India’s vaccination drive —  as a product “licensed by the central government”, which will be available to all “interested countries for free, until perpetuity”. In an interview to ThePrint, Dr R.S. Sharma, chairperson of the Empowered Committee […]

Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against Covid-19

Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 percent effective against COVID-19. It also added that Covaxin gives 65.2 percent protection against the SARS-CoV-2, B.1.617.2 Delta variant. “Efficacy analysis demonstrates Covaxin to be 77.8 percent effective against symptomatic COVID-19, through […]

Wheelchair users with spinal cord injury need repairs in past 6 months, study finds

Among wheelchair users with spinal cord injury, 42 percent reported adverse consequences related to needing wheelchair repair, according to a team of experts in spinal cord injury rehabilitation, according to a collaborative study led by a team of international researchers at Kessler Foundation. The article ‘Factors Influencing Incidence of Wheelchair Repairs and Consequences Among Individuals with Spinal Cord Injury’ […]

Covid-19 Delta variant detected in 96 countries, says WHO

The Delta COVID-19 variant, first identified in India, has already been detected in 96 countries, 11 more than last week, the World Health Organisation (WHO) said in its weekly epidemiological update on Wednesday. The Delta variant, also referred to as a “double mutant” because it carries two mutations, is 55 percent more transmissible than the […]

Oxford study says mixing Covid-19 vaccines gives good protection

Amid the global shortage of the COVID-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. According to the study, ‘mixed’ schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks […]